• Strata Oncology Announces Partnerships with Five Additional Health Systems

    Aug 17, 2019, 14:08 PM by Michael Croft
    BELFORD, NJ, US - Aug 16, 2019 - ANN ARBOR, Mich. -- Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics, today announced Baptist Health (KY), Lehigh Valley Health Network (PA), Marshfield Clinic (WI), MultiCare Health System (WA), and Prisma Health (SC) have joined the Strata Precision Oncology Network™ (the "Network")
    Full story
  • U.K. Firm Creates Operating System To Handle Massive Genomic Patient Data Sets

    Aug 16, 2019, 17:38 PM by Michael Croft
    Forbes | We're making work digital on every desktop, we're empowering digital sensors in the Internet of Things (IoT) on every street corner, we're building smart digital AI-powered IT systems with machine learning and decision-making abilities to automate our lives… and we're digitizing ourselves as well.
    Full story
  • Creative Enzymes Has Upgraded Four Enzymes Services for Bio-researchers

    Aug 16, 2019, 04:47 AM by Michael Croft
    NEW YORK, NY - Aug 16, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has upgraded four enzymes related services, such as enzyme expression and purification, and enzyme engineering services for researchers working in the life science field
    Full story
  • 20% Enrollment For All of Us Program, Challenges Remain

    Aug 15, 2019, 12:55 PM by Michael Croft
    Bio-IT World | The All of Us research program announced updates today in a special report published in the New England Journal of Medicine. As of July 2019, the All of Us program has enrolled more than 175,000 core participants (those who contributed personal information, biospecimens, and physical measurements and who agreed to share EHR data) and more than 230,000 total participants; an additional 40,000 participants have registered on the website, the authors report. “More than 80% of these participants are from groups that have been historically underrepresented in biomedical research,” the authors observe.
    Full story
  • New BioIVT Research Examines Potential Link Between HIV Integrase Inhibitor Drugs and Neural Tube Defects During Pregnancy

    Aug 15, 2019, 08:28 AM by Michael Croft
    WESTBURY, NY - Aug 15, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways
    Full story
  • Size really does matter when purchasing equipment for laboratories

    Aug 14, 2019, 12:15 PM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Aug 14, 2019 - Laboratories are nearly always short of space which means bulky or very heavy equipment can’t be accommodated or has to be housed away from the laboratory
    Full story
  • Tackling the Affinity Gap at Amgen

    Aug 14, 2019, 11:55 AM by Michael Croft
    Bio-IT World At Amgen, Agnieszka Kielczewska had a problem. The AMGN12 antibody, derived from an in vivo immunization of the XenoMouse, demonstrated single digit pM affinity to the human orthologue of the target protein, but a 200-fold weaker binding to the monkey orthologue. In order to conduct toxicology studies in non-human primate species, Amgen needed that affinity difference to be closer to 10-fold.
    Full story
  • Creative Biolabs Has Updated Its Product Type for Therapeutic Antibodies

    Aug 14, 2019, 02:45 AM by Michael Croft
    SHIRLEY, NY - Aug 13, 2019 - August 13, 2019, as a leading supplier and manufacturer in antibody field, Creative Biolabs recently has updated its new product types for therapeutic antibody, which has at least three types of mechanisms
    Full story
  • Nvidia just made it easier to build smarter chatbots and slicker fake news

    Aug 13, 2019, 10:42 AM by Michael Croft
    MIT Technology Review | Chipmaker Nvidia is betting that AI's language skills will advance rapidly-it's releasing a powerful tool for putting together chatty programs.
    Full story
  • Biobanking Is Changing The World

    Aug 13, 2019, 10:29 AM by Michael Croft
    Forbes | With the evolution of biobanks rapidly enabling the creation of massive collections of biological material and associated information, how are these collected terabytes of data transforming nations?
    Full story
  • AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

    Aug 13, 2019, 05:01 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC - Aug 13, 2019 - AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression
    Full story
  • National Genomic Data Initiatives: A Worldwide Update

    Aug 12, 2019, 09:55 AM by Michael Croft
    Bio-IT World | The global movement toward the application of genomics to medical practice is exciting because it is essentially "precision medicine come real," says Ewan Birney, chair of the Global Alliance for Genomics and Health (GA4GH). But which countries are involved? And what progress has been made so far? Bio-IT World’s overview offers an update on currently active national government-funded genomic-medicine initiatives, grouped by area of emphasis.
    Full story
  • Signant Health Launches Partner Program to Team with Clinical Research Organizations (CROs) Committed to Improving Clinical Trials with Patient-Centric Technology

    Aug 12, 2019, 09:19 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Aug 12, 2019 - Signant Health (signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions
    Full story
  • Creative Enzymes Has Launched several enzymes services for Bio-researchers

    Aug 12, 2019, 05:52 AM by Michael Croft
    NEW YORK, NY - Aug 12, 2019 - Creative Enzymes Has Launched several enzymes services for Bio-researchers SHIRLEY, NY - Aug, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has launched five enzymes related services, such as biocatalysis service, enzyme engineering, enzyme modification, enzyme conjugation, and enzyme formulation for researchers working in the life science field
    Full story
  • Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing

    Aug 12, 2019, 04:19 AM by Michael Croft
    SHIRLEY, NY - Aug 12, 2019 - It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy
    Full story
  • Bacteria On Tumors Influences Immune Response, Survival Of Patients With Pancreatic Cancer

    Aug 9, 2019, 09:05 AM by Michael Croft

    Bio-IT World News Brief | A team led by researchers from The University of Texas MD Anderson Cancer Center reports that a key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response.

    Full story
  • Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors

    Aug 8, 2019, 11:09 AM by Michael Croft
    HOPKINTON, MA, UNITED STATES - Aug 8, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that its Investigational New Drug (IND) application for a Phase 1 trial of SB 11285, the company’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist development candidate, is now effective following clearance by the FDA
    Full story
  • WCG Acquires PharmaSeek, LLC

    Aug 8, 2019, 10:44 AM by Michael Croft
    PRINCETON, NJ - Aug 8, 2019 - The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites
    Full story
  • Shimmer Wins Two GHP International Life Sciences Awards for its Wearable Sensor Technology

    Aug 7, 2019, 10:12 AM by Michael Croft
    CAMBRIDGE, MA, US - Aug 7, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019
    Full story
  • BioIVT to Host Symposium Highlighting Industry Progress in Immuno-oncology Drug Discovery Research

    Aug 7, 2019, 08:09 AM by Michael Croft
    WESTBURY, NY - Aug 7, 2019 - Aug. 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled "Innovation in Immuno-oncology: Breaking Down the Barriers" on Aug
    Full story